What is the Share Price of Skybiotech Healthcare Limited?

Skybiotech Healthcare Limited share price is ₹133.85 As on 08 February, 2026|00:55

Home
>
Stocks
>
Skybiotech Healthcare Limited

Skybiotech Healthcare Limited Share Price

Q: What is the Market Cap of Skybiotech Healthcare Limited?

The Market Cap of Skybiotech Healthcare Limited is ₹25.6 As on 08 February, 2026|00:55

Q: What is PE Ratio of Skybiotech Healthcare Limited?

The P/E ratio of Skybiotech Healthcare Limited is 0 As on 08 February, 2026|00:55

Q: What is PB Ratio of Skybiotech Healthcare Limited?

The PB ratio of Skybiotech Healthcare Limited is 2.18 As on 08 February, 2026|00:55

₹ 0.00 0 (0%)
Updated on 01-01-1970 5:30 AM

Stock Rating

BSE

Pros 1

Cons 6

Skybiotech Healthcare Limited Price Performance

Day's Low
₹0

Day's High
₹0

₹ 0

52-w low
₹0

52-w high
₹0

Day's open
₹0
Previous close
₹0
VWAP
₹0
Lower price band
₹0
Upper price band
₹0

Today's Market Action

Its last traded stock price on BSE was 133.85 down by -4.97%. The total volume of shares on NSE and BSE combined was 6 shares. Its total combined turnover was Rs 0.00 crores.

Skybiotech Healthcare Limited Medium and Long Term Market Action

The stock price of Skybiotech Healthcare Limited is down by 0% over the last one month. Don't forget to check the full stock price history in the table below.

Skybiotech Healthcare Limited Fundamentals

Market Cap (Cr): 25.6
Book Value (₹):
Stock P/E:
Revenue (Cr):
Total Debt (Cr):

Face Value (₹):
Roce (%):
ROE (%):
Earnings (Cr):
Promoter’s Holdings (%):

EPS (₹):
Debt to Equity:
Dividend Yield (%):
Cash (Cr):

Skybiotech Healthcare Limited Mutual fund holdings and trends

FUND NAME	Quantity	Monthly Change (Qty)

Skybiotech Healthcare Limited Shareholding Pattern

Similar Stocks

Company	Price	Market Cap (Cr)	P/E

About Skybiotech Healthcare Limited

Data not available.

Skybiotech Healthcare Limited FAQ's

What is Share Price of Skybiotech Healthcare Limited?

What is the Market Cap of Skybiotech Healthcare Limited?

What is PE Ratio of Skybiotech Healthcare Limited?

What is PB Ratio of Skybiotech Healthcare Limited?

What is the CAGR of Skybiotech Healthcare Limited?

How to Buy Skybiotech Healthcare Limited Share?

Can I buy Skybiotech Healthcare Limited from Samco?

How do I buy Skybiotech Healthcare Limited from Samco?

Financials

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

Zero Debt
The company has almost nil to negligible debt to equity ratio of 0.00. Considering the fact that the business is debt free, equity shareholders shall carry lower risk of holding the stock.

Cons

Low Sustainable RoE
The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
Low Return on Capital Employed
The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
Poor Cash Flow Conversion
The business has very poor cash conversion ratio of only -71.28% of operating earnings getting converted into operating cash flow. This implies that increase in profits has not translated into higher cash flows for the business and incrementally higher investments in working capital which works negatively for shareholders.
Negative operating earnings and interest coverage
The company has a negative operating earnings and a negative Interest coverage ratio of -Infinity times which implies that the company has no operating earnings to pay for interest which is currently being paid out of capital and/or other income. This is extremely negative for shareholders.
Low Pricing Power & High Competition
The business has extremely low pricing power and is vulnerable to competitive pressure which can significantly impact shareholder returns.
Poor Corporate Governance
The general corporate governance standards of the company are poor which can negatively impact shareholder value and returns.

Valuation Analysis

Margin of safety
(08/02/2026)

124

Margin of Safety Index: Very High

0% People are bullish about Skybiotech Healthcare Limited

0 % People are bearish about Skybiotech Healthcare Limited

What is your opinion about this Stock?

Historical Data

Date	Open	High	Low	Close	Volume	Daily Change %